Central Nervous System

GLP-1 Receptor Activation Linked to Reduced Depression, Bipolar Disorder Risk

by

Genetic Insights into GLP-1R and Mental Health Genetic evidence suggests that lifelong activation of the glucagon-like peptide-1 receptor (GLP-1R) may reduce risks of major depressive disorder (MDD) and bipolar disorder (BD), according to a study published in Translational Psychiatry. Researchers used Mendelian randomization (MR) to analyze data from genome-wide association studies (GWASs), linking genetic variants … Read more

New Wearable Robotic System Restores Hand Function

by

A new wearable neurorobotic system called SensoExo has demonstrated the ability to restore tactile sensation and grip control in patients with neurological hand impairments. Developed by researchers at the Medical University of Vienna, ETH Zurich, the Technical University of Munich, and the Medical Faculty Belgrade, the device combines a hand exoskeleton with transcutaneous electrical nerve … Read more

Researchers Create Detailed Map of Smell Receptors in Mouse Nose

by

The End of the ‘Random’ Nose: Why the New Smell Map Changes Everything For decades, science textbooks taught a simple, if slightly chaotic, story about how we smell: that olfactory receptors were scattered somewhat randomly across the nasal epithelium. It was the “wild west” of the senses—unlike the precise mapping found in our eyes or … Read more

Scientists show gut bacteria can reach the brain in mice and reveal a potential vagus nerve pathway

by

The Gut-Brain Connection: How Diet and Bacteria Influence Neurological Health The intricate relationship between the gut and the brain, often called the gut-brain axis (GBA), is gaining increasing attention from researchers. A recent study published in PLOS Biology has revealed a surprising finding: live bacteria from the gut can travel to the brain in mice, … Read more

ADHD prescriptions surged during the COVID-19 pandemic

by

The ADHD Prescription Surge: What’s Driving the Trend and What Does It Mean for the Future? The COVID-19 pandemic dramatically reshaped healthcare access, and with it, patterns of ADHD diagnosis and treatment. A recent study published in the Canadian Medical Association Journal (CMAJ) reveals a significant surge in stimulant prescriptions for adults in Ontario, Canada, … Read more

Investigating microglia’s role in Alzheimer’s pathology

by

Unlocking Alzheimer’s Secrets: How Targeting Microglia with TREM2 Agonists Could Revolutionize Treatment Alzheimer’s disease (AD), a devastating neurodegenerative disorder, continues to challenge medical science. Recent research, published in BIO Integration, offers a promising new avenue for treatment: manipulating the activity of microglia, the brain’s resident immune cells, using a TREM2 agonist monoclonal antibody (hT2AB). This … Read more

Ride Cincinnati grant funds research on immune activating wafer for glioblastoma treatment

by

The Future of Glioblastoma Treatment: Harnessing the Immune System and Personalized Medicine A $40,000 grant awarded to researchers at the University of Cincinnati Cancer Center marks a significant step forward in the fight against glioblastoma, one of the most aggressive and deadly forms of brain cancer. The project, funded by Ride Cincinnati, focuses on a … Read more

EMA Recommends Aqneursa for Niemann-Pick Type C

by

Aqneursa: A Glimmer of Hope for Niemann-Pick Type C Disease? The Future of Rare Disease Treatments The recent European Medicines Agency (EMA) recommendation for Aqneursa, a potential new treatment for the neurological manifestations of Niemann-Pick type C (NPC) disease, marks a significant moment in the fight against this devastating rare disorder. As a journalist specializing … Read more

EMA Recommends Aqneursa for Niemann-Pick Type C Disease

by

Aqneursa: A Glimmer of Hope for Niemann-Pick Type C Disease? Examining the Future of Rare Disease Treatments The recent recommendation by the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) to grant marketing authorization for Aqneursa (levacetylleucine) in the European Union marks a significant moment for individuals affected by Niemann-Pick type C … Read more

Immune system shows unique signature in Parkinson’s patients

by

Unlocking Parkinson’s: New Biomarkers Could Revolutionize Diagnosis Parkinson’s disease, a condition primarily known for its impact on the central nervous system, is now understood to have a significant connection with the immune system. Recent advancements in neuroscience are shining a light on this previously under-explored area, promising new avenues for earlier and more accurate diagnoses. … Read more

© 2026 Newsy Today. All rights reserved.


For contact, advertising, copyright, issues email: [email protected]

For contact, advertising, copyright, issues email: [email protected]